Depression-related cognitive impairment: possibilities for its pharmacological treatment.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Affective Disorders

• Publication date

  1996-01-22

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/0165-0327(95)00070-4PMID 8821310
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The contribution of hypercortisolaemia to the cognitive decline of geriatric depression

  1995cited by this paper
• The psychotropic effects of inhibitors of steroid biosynthesis in depressed patients refractory to treatment.

  1995cited by this paper
• Pharmacology of reversible and selective inhibitors of monoamine oxidase type A

  1995cited by this paper
• Improvement in depression-related cognitive dysfunction following ECT.

  1995cited by this paper
• Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression.

  1995cited by this paper
• Lessons from social psychiatry for the biology of depression

  1995cited by this paper
• Late-Life Depressive Disorder in the Community

  1995cited by this paper
• Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment.

  1995cited by this paper
• Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?

  1995cited by this paper
• Adrenal Gland Volume in Major Depression Increase During the Depressive Episode and Decrease With Successful Treatment

  1995cited by this paper
• Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease.

  1995cited by this paper
• Effects of acetyl-L-carnitine treatment and stress exposure on the nerve growth factor receptor (p75NGFR) mRNA level in the central nervous system of aged rats.

  1995cited by this paper
• Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.

  1994cited by this paper
• Endocrine function in alcoholic Korsakoff's syndrome.

  1994cited by this paper
• Antidepressant Effect of Lithium in Patients with Systemic Lupus Erythematosus and Cerebral Infarction, Treated with Corticosteroid

  1994cited by this paper
• Therapy of Cushing's syndrome with steroid biosynthesis inhibitors.

  1994cited by this paper
• Diurnal variation of mood and neuropsychological function in major depression with melancholia.

  1994cited by this paper
• Glucocorticoids and the genesis of depressive illness

  1994cited by this paper
• Glucocorticoid-induced impairment in declarative memory performance in adult humans

  1994cited by this paper
• Post-ECT increases in MRI regional T2 relaxation times and their relationship to cognitive side effects: a pilot study.

  1994cited by this paper
• Cognitive dysfunctions in recovered melancholic patients.

  1994cited by this paper
• Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide.

  1994cited by this paper
• Depression Induced Cognitive Impairment

  1994cited by this paper
• Pattern of Activation of the Hypothalamic‐Pituitary‐Adrenal Axis in Acute Stroke: Relation to Acute Confusional State, Extent of Brain Damage, and Clinical Outcome

  1994cited by this paper
• Differentiation of Dementia and Depression by Memory Tests: A Meta-Analysis

  1994cited by this paper
• Cerebral atrophy and plasma cortisol levels in alcoholics after short or a long period of abstinence.

  1994cited by this paper
• Cognitive function in depression: its relationship to the presence and severity of intellectual decline

  1994cited by this paper
• Does ECT alter brain structure?

  1994cited by this paper
• Depression coexisting with dementia. Evaluation and treatment.

  1994cited by this paper
• Effects of electroconvulsive therapy on the CRH-ACTH-cortisol system in melancholic depression: preliminary findings.

  1994cited by this paper
• Glucocorticoids and the Genesis of Depressive Illness a Psychobiological Model

  1994cited by this paper
• Refractory depression : current strategies and future directions

  1994cited by this paper
• Cushing's Syndrome and Depression:

  1994cited by this paper
• Steroid modulation of human memory: biochemical correlates.

  1993cited by this paper
• Attenuation of hypercortisolemia in fawn-hooded rats by antidepressant drugs.

  1993cited by this paper
• Ketoconazole administration in hypercortisolemic depression.

  1993cited by this paper
• Steroid modulation of human memory: biochemical correlates.

  1993cited by this paper
• Depression in Old Age a Reconsideration of Cerebral Disease in Relation to Outcome

  1993cited by this paper
• Long-term affective and cognitive outcome in depressed older adults.

  1993cited by this paper
• The course of geriatric depression with "reversible dementia": a controlled study.

  1993cited by this paper
• Memory impairment in Cushing's disease

  1993cited by this paper
• Two-Year Survival in Patients With Mixed Symptoms of Depression and Cognitive Impairment: Comparison With Major Depression and Primary Degenerative Dementia.

  1993cited by this paper
• Hypercortisolemia and hippocampal changes in depression.

  1993cited by this paper
• The DST as a predictor of outcome in depression: a meta-analysis.

  1993cited by this paper
• Cognitive function in the affective disorders: a prospective study.

  1993cited by this paper
• Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects.

  1993cited by this paper
• The medical treatment of Cushing's syndrome.

  1993cited by this paper
• Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions

  1993cited by this paper
• Geriatric depression: age of onset and dementia.

  1993cited by this paper
• The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications.

  1992cited by this paper
• Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo.

  1992cited by this paper
• Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons.

  1992cited by this paper
• Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene

  1992cited by this paper
• The Efficacy and Safety of Maintenance ECT in Geriatric Patients

  1992cited by this paper
• Antiglucocorticoid strategies in hypercortisolemic states.

  1992cited by this paper
• Re-examination of the glucocorticoid hypothesis of stress and aging.

  1992cited by this paper
• Primary or depressive dementia: Clinical features

  1992cited by this paper
• Tianeptine attenuates stress-induced morphological changes in the hippocampus.

  1992cited by this paper
• Stress, the Aging Brain, and the Mechanisms of Neuron Death

  1992cited by this paper
• Cellular mechanisms underlying the development and expression of individual differences in the hypothalamic-pituitary-adrenal stress response.

  1991cited by this paper
• Cognitive outcome following tricyclic and electroconvulsive treatment of major depression in the elderly.

  1991cited by this paper
• Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications.

  1991cited by this paper
• The aging personality

  1991cited by this paper
• A follow‐up study of elderly depressives and Alzheimer‐type dementia—relationship with DST status

  1991cited by this paper
• Ventricular enlargement and caudate hyperdensity in elderly depressives.

  1991cited by this paper
• Effect of acetyl-L-carnitine on geriatric patients suffering from dysthymic disorders.

  1990cited by this paper
• Stress-adaptation failure hypothesis of Alzheimer's disease.

  1990cited by this paper
• Neuropsychological deficits and CT scan changes in elderly depressives

  1990cited by this paper
• Full and Abbreviated Courses of Maintenance Electroconvulsive Therapy.

  1990cited by this paper
• Evaluation of the effects of L-acetylcarnitine on senile patients suffering from depression.

  1990cited by this paper
• Cognition-enhancing effects of moclobemide, a reversible MAO inhibitor, in humans.

  1990cited by this paper
• Age-related changes of the mossy fibre system in rat hippocampus: effect of long term acetyl-L-carnitine treatment.

  1989cited by this paper
• Acetyl‐L‐carnatine reduces the age‐dependent loss of glucocorticoid receptors in the rat hippocampus: An autoradiographic study

  1989cited by this paper
• Structural brain CT changes and cognitive deficits in elderly depressives with and without reversible dementia (‘pseudodementia’)

  1989cited by this paper
• Long-Term Follow-up of Depressive Pseudodementia of the Aged *

  1989cited by this paper
• Long-term Acetyl-l-carnitine preserves spatial learning in the senescent rat

  1989cited by this paper
• Cognitive impairment and cortisol resistance to dexamethasone suppression in elderly depression.

  1989cited by this paper
• The effects of moclobemide on cognition.

  1989cited by this paper
• Chemical adrenalectomy reduces hippocampal damage induced by kainic acid.

  1988cited by this paper
• Review in Psychiatry

  1988cited by this paper
• Open-trial response to antidepressant treatment in elderly patients with mixed depression and cognitive impairment.

  1987cited by this paper
• Modulation of brain aging correlates by long-term alterations of adrenal steroids and neurally-active peptides.

  1987cited by this paper
• Dexamethasone suppression in dementia, depression, and normal aging.

  1986cited by this paper
• Cognitive impairment in late-life depression: clinical correlates and treatment implications.

  1986cited by this paper
• Cushing's syndrome after treatment: changes in cortisol and ACTH levels, and amelioration of the depressive syndrome.

  1986cited by this paper
• Depression in patients referred to a dementia clinic. A three-year prospective study.

  1985cited by this paper
• Effects of electroconvulsive therapy on neuropsychological function and circulating levels of ACTH, cortisol, prolactin, and TSH in patients with major depressive illness

  1985cited by this paper
• The dexamethasone suppression test and mood following stroke.

  1985cited by this paper
• Moclobemide in the treatment of depression in demented geriatric patients

  1985cited by this paper
• Ketoconazole therapy in Cushing's disease.

  1985cited by this paper
• Reversible steroid dementia in patients without steroid psychosis.

  1984cited by this paper
• Physiological functions of glucocorticoids in stress and their relation to pharmacological actions.

  1984cited by this paper
• Criteria for Diagnosing Reversible Dementia Caused by Depression: Validation by 2-year Follow-up

  1984cited by this paper
• Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors.

  1983cited by this paper
• Lithium prophylaxis of corticotropin-induced psychosis.

  1979cited by this paper

• Sleep, Cognition and Cortisol in Addison’s Disease: A Mechanistic Relationship

  2021cites this paper
• A comparative study to assess the effect of escitalopram and amitriptyline on psychomotor functions in patients of depression

  2020cites this paper
• Depressive symptoms, cognitive impairment, and metabolic syndrome in community‐dwelling elderly in Southern Taiwan

  2015cites this paper
• Effect of Selective Serotonin Reuptake Inhibitors on Psychomotor Function in Patients of Depression: A Comparative Study of Sertraline and Fluoxetine

  2015cites this paper
• Harmful effects of functional hypercortisolism: a working hypothesis

  2014cites this paper
• Local amplification of glucocorticoids in the aging brain and impaired spatial memory

  2012cites this paper
• Hydrocortisone responsiveness in Gulf War veterans with PTSD: Effects on ACTH, declarative memory hippocampal [18F]FDG uptake on PET

  2010cites this paper
• Electroconvulsive Therapy in Late-Life Depression

  2009cites this paper
• Neurocognitive correlates of response to treatment in late-life depression.

  2008cites this paper
• Geriatric depression and cognitive impairment

  2007cites this paper
• Depression as a risk factor for later dementia: a robust relationship?

  2005cites this paper
• Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia.

  2004cites this paper
• Core biological marker candidates of Alzheimer’s disease – perspectives for diagnosis, prediction of outcome and reflection of biological activity

  2004cites this paper
• Impaired Declarative Memory in Depressed Patients Is Slow To Recover: Clinical Experience

  2004cites this paper
• Impaired declarative memory in depressed patients is slow to recover: clinical experience.

  2004cites this paper
• A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects.

  2004cites this paper
• Clinical and Neurobiological Effects of Tianeptine and Paroxetine in Major Depression

  2003cites this paper
• Major Depression and Cognitive Decline After 11.5 Years: Findings from the ECA Study

  2003cites this paper
• Electroconvulsive Stimuli Alter the Regional Concentrations of Nerve Growth Factor, Brain-Derived Neurotrophic Factor, and Glial Cell Line-Derived Neurotrophic Factor in Adult Rat Brain

  2002cites this paper
• Pharmacologic considerations for serotonin reuptake inhibitor use by aviators.

  2002cites this paper
• Hypericum Extract and Hyperforin: Memory-Enhancing Properties in Rodents

  2001cites this paper
• Corticosteroids and cognition.

  2001cites this paper
• Effects of the monoamine oxidase A inhibitor moclobemide on hippocampal plasticity in GR-impaired transgenic mice.

  2001cites this paper
• Heterogeneity of Hippocampal GABAA Receptors: Regulation by Corticosterone

  2001cites this paper
• Hypericum extract and hyperforin: memory-enhancing properties in rodents.

  2001cites this paper
• Cognitive and Psychomotor Effects of Antidepressants with Emphasis on Selective Serotonin Reuptake Inhibitors and the Depressed Elderly Patient

  2000cites this paper
• Conventional and new antidepressant drugs in the elderly.

  2000cites this paper
• Depressive Symptoms in the Frail Elderly: Physical and Psycho-Social Correlates

  1999cites this paper
• Is there a difference between elderly and younger patients with regard to the symptomatology and aetiology of depression?

  1998cites this paper
• Current awareness in human psychopharmacology

  1996cites this paper